Cited by 440Dementia and Cognitive Impairment ResearchNeuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatments

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Inflammatory markers and the risk of Alzheimer disease: The Framingham Study

Tan, Z. S., Beiser, A. S., Vasan, R. S., Roubenoff, R., Dinarello, C. A., Harris, T. B., Benjamin, E. J., Au, R., Kiel, D. P., Wolf, P. A., Seshadri, S.·2007·Neurology

DOI 10.1212/01.wnl.0000263217.36439.da

Open this paper in CoChat — free account

Abstract

OBJECTIVE: To examine whether serum cytokines and spontaneous production of peripheral blood mononuclear cell (PBMC) cytokines are associated with the risk of incident Alzheimer disease (AD). METHODS: We followed 691 cognitively intact community-dwelling participants (mean age 79 years, 62% women) and related PBMC cytokine production (tertiles of spontaneous production of interleukin 1 [IL-1], IL-1 receptor antagonist, and tumor necrosis factor alpha [TNF-alpha]) and serum C-reactive protein and interleukin 6 (IL-6) to the risk of incident AD. RESULTS: Adjusting for clinical covariates, individuals in the top two tertiles (T2 and T3) of PBMC production of IL-1 or the top tertile (T3) of PBMC production of TNF-alpha were at increased risk of developing AD (multivariable-adjusted hazard ratio [HR] for IL-1 T2 = 2.84, 95% CI 1.09 to 7.43; p = 0.03 and T3 = 2.61, 95% CI 0.96 to 7.07; p = 0.06; for TNF-alpha, adjusted HR for T2 = 1.30, 95% CI 0.53 to 3.17; p = 0.57 and T3 = 2.59, 95% CI 1.09 to 6.12; p = 0.031]) compared with those in the lowest tertile (T1). INTERPRETATION: Higher spontaneous production of interleukin 1 or tumor necrosis factor alpha by peripheral blood mononuclear cells may be a marker of future risk of Alzheimer disease (AD) in older individuals. These data strengthen the evidence for a pathophysiologic role of inflammation in the development of clinical AD.

Integrity signals

Registry

Crossref · 10.1212/01.wnl.0000263217.36439.da

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

“Mini-mental state”
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Cerebral amyloid angiopathy. A critical review.
Vinters, H. V. (1987) · Stroke · doi:10.1161/01.str.18.2.311 · Cited by 1,070
Inflammatory mediators in the elderly
Krabbe, K. S., Pedersen, M., & Bruunsgaard, H. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2004.01.009 · Cited by 928
Plasma Concentration of C-Reactive Protein and Risk of Ischemic Stroke and Transient Ischemic Attack: The Framingham Study
Rost, N. S., Wolf, P. A., Kase, C. S., Kelly‐Hayes, M., Silbershatz, H., Massaro, J. M., D’Agostino, R. B., Franzblau, C., & Wilson, P. W. F. (2001) · Stroke · doi:10.1161/hs1101.098151 · Cited by 806
Self-citation
Passage of cytokines across the blood–brain barrier
Banks, W. A., Kastin, A. J., & Broadwell, R. D. (1996) · Neuroimmunomodulation · doi:10.1159/000097202 · Cited by 778
Inflammatory Markers and Risk of Heart Failure in Elderly Subjects Without Prior Myocardial Infarction
Vasan, R. S., SULLIVAN, L. M., Roubenoff, R., Dinarello, C. A., Harris, T. B., Benjamin, E. J., Sawyer, D. B., Levy, D. A., Wilson, P. W. F., & D’Agostino, R. B. (2003) · Circulation · doi:10.1161/01.cir.0000057810.48709.f6 · Cited by 763
Self-citation
β-Amyloid Stimulation of Microglia and Monocytes Results in TNFα-Dependent Expression of Inducible Nitric Oxide Synthase and Neuronal Apoptosis
Combs, C. K., Karlo, J. C., Kao, S.-C., & Landreth, G. E. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-04-01179.2001 · Cited by 721
Inflammatory markers and cognition in well-functioning African-American and white elders
Yaffe, K., Lindquist, K., Penninx, B. W., Simonsick, E. M., Pahor, M., Kritchevsky, S., Launer, L., Kuller, L., Rubin, S., & Harris, T. (2003) · Neurology · doi:10.1212/01.wnl.0000073620.42047.d7 · Cited by 706
Self-citation

Show all 43 references

Research works printed but not linked: 3

10.1161/hs1101.098151 · DOI
Tarkowski E, Wallin A, Blennow K, Tarkowski A. Local production of TNF-a, a potent neuroprotective agent, in Alzheimer's disease and vascular dementia. J Clin Immunol 1999;19:223–230.
Paolisso G, Rizzo MR, Mazziotti G, et al. Advancing age and insulin resistance: role of plasma tumor necrosis factor-alpha. Am J Physiol Endocrinol Metab 1998;38:E294–E299.

Sorted by citations

Items 301–400 of 440

Elevations in Serum Dickkopf-1 and Disease Progression in Community-Dwelling Older Adults With Mild Cognitive Impairment and Mild-to-Moderate Alzheimer’s Disease
Tay, L., Leung, B. P. L., Yeo, A., Chan, M. Y., & Lim, W. S. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00278 · Cited by 18
Finding a pathological diagnosis for A lzheimer's disease: Are inflammatory molecules the answer?
Bhamra, M. S., & Ashton, N. J. (2012) · Electrophoresis · doi:10.1002/elps.201200161 · Cited by 21
Peripheral inflammatory markers in amnestic mild cognitive impairment
Karim, S., Hopkins, S., Purandare, N. B., Crowther, J., Morris, J., Tyrrell, P. J., & Burns, A. S. (2013) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.3988 · Cited by 18
Interrupting the inflammatory cycle in chronic diseases—Do gap junctions provide the answer?
Green, C. R., & Nicholson, L. F. B. (2008) · Cell Biology International · doi:10.1016/j.cellbi.2008.09.006 · Cited by 18
Non-invasive, ultra-sensitive, high-throughput assays to quantify rare biomarkers in the blood
Freudenberg, J. A., Bembas, K., Greene, M. I., & Zhang, H. (2008) · Methods · doi:10.1016/j.ymeth.2008.05.005 · Cited by 18
Integrating neuroinflammation biomarkers into the ATN(X) framework: Advances in Alzheimer's pathogenesis, diagnosis, and insights from non‐human primate models
Jin, Z., Lu, Y., Tang, H., & Cui, H. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70472 · Cited by 24
Effect of time-varied magnetic field on inflammatory response in macrophage cell line RAW 264.7
Ross, C. L., & Harrison, B. S. (2012) · Electromagnetic Biology and Medicine · doi:10.3109/15368378.2012.701191 · Cited by 17
The protected survivor model: Using resistant successful cognitive aging to identify protection in the very old
Silverman, J. M., & Schmeidler, J. (2017) · Medical Hypotheses · doi:10.1016/j.mehy.2017.10.022 · Cited by 17
Blood-based inflammation biomarkers of neurocognitive impairment in people living with HIV
Swanta, N. K., Aryal, S., Nejtek, V. A., Shenoy, S., Ghorpade, A., & Borgmann, K. (2020) · Journal of NeuroVirology · doi:10.1007/s13365-020-00834-3 · Cited by 18
Advances in Vascular Cognitive Impairment 2007
Gorelick, P. B., & Bowler, J. V. (2008) · Stroke · doi:10.1161/strokeaha.107.509570 · Cited by 17
The Framingham Heart Study: impact on the prevention and control of cardiovascular diseases in India.
Reddy, K., & Satija, A. (2010) · Progress in cardiovascular diseases · doi:10.1016/j.pcad.2010.02.011 · Cited by 20
Regulation of Neuroinflammatory Signaling by PPARγ Agonist in Mouse Model of Diabetes
Piątkowska‐Chmiel, I., Herbet, M., Gawrońska‐Grzywacz, M., & Dudka, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105502 · Cited by 17
Circulating biomarkers that predict incident dementia
Weinstein, G., & Seshadri, S. S. (2014) · Alzheimer s Research & Therapy · doi:10.1186/alzrt235 · Cited by 16
Self-citation
Dietary Fish Oil Decreases the Proportion of Classical Monocytes in Blood in Healthy Mice but Increases Their Proportion upon Induction of Inflammation
Arnardottir, H. H., Freysdóttir, J., & Harðardóttir, I. (2012) · Journal of Nutrition · doi:10.3945/jn.111.153221 · Cited by 16
No relationship between lipoprotein-associated phospholipase A2, proinflammatory cytokines, and neopterin in Alzheimer's disease
Savaş, S., Kabaroğlu, C., Alpman, A., Saraç, F., Yalcin, M. A., Parıldar, Z., Özkınay, F., Kumral, E., & Akçiçek, F. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.01.014 · Cited by 16
Space-Dependent Glia–Neuron Interplay in the Hippocampus of Transgenic Models of β-Amyloid Deposition
Lana, D., Ugolini, F., & Giovannini, M. G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249441 · Cited by 17
New Perspectives for the Diagnosis of Alzheimers Disease
Urbanelli, L., Magini, A., Ciccarone, V. A., Trivelli, F., Polidoro, M., Tancini, B., & Emiliani, C. (2009) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488909789104839 · Cited by 17
Differential Glial Response and Neurodegenerative Patterns in CA1, CA3, and DG Hippocampal Regions of 5XFAD Mice
Nairuz, T., Heo, J.-C., & Lee, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212156 · Cited by 16
Time-Dependent Compensatory Responses to Chronic Neuroinflammation in Hippocampus and Brainstem: The Potential Role of Glutamate Neurotransmission
Brothers, H. M. (2013) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000110 · Cited by 15
Therapeutic Potential of Vaccines for Alzheimer‘s Disease
Shah, S., & Federoff, H. J. (2011) · Immunotherapy · doi:10.2217/imt.10.94 · Cited by 15
Osteoarthritis Was Associated With a Faster Decline in Hippocampal Volumes in Cognitively Normal Older People
Li, X., Tong, Q., Gao, J., Liu, C., Initiative, A. D. N., & Liu, Y. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00190 · Cited by 16
Increased expression of Interleukin-18 receptor in blood cells of subjects with Mild Cognitive Impairment and Alzheimer’s disease
Salani, F., Ciaramella, A., Bizzoni, F., Assogna, F., Caltagirone, C., Spalletta, G., & Bossù, P. (2012) · Cytokine · doi:10.1016/j.cyto.2012.11.001 · Cited by 15
Does the Interplay Between Aging and Neuroinflammation Modulate Alzheimer’s Disease Clinical Phenotypes? A Clinico-Pathological Perspective
Taipa, R. J. F., Sousa, A. L., Pires, M. M., & Sousa, N. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160121 · Cited by 15
Cortisol and IgA are Involved in the Progression of Alzheimer’s Disease. A Pilot Study
Ortí, J. E. D. L. R., Prado‐Gascó, V., Sancho-Castillo, S., Rochina, M. J., Gómez, F. J. R., & García-Pardo, M. P. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-019-00699-z · Cited by 14
Immune abnormalities and differential gene expression in the hippocampus and peripheral blood of patients with Alzheimer’s disease
Wang, X., Wang, D., Su, F., Li, C., & Chen, M. (2022) · Annals of Translational Medicine · doi:10.21037/atm-21-4974 · Cited by 14
Fighting fire with fire: The immune system might be key in our fight against Alzheimer’s disease
Dujardin, P., Vandenbroucke, R. E., & Hoecke, L. V. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.01.004 · Cited by 14
Proteomic Signature and mRNA Expression in Hippocampus of SAMP8 and SAMR1 Mice during Aging
Reale, M., Costantini, E., Aielli, L., Giuseppe, F. D., Angelucci, S., Kamal, M. A., & Greig, N. H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315097 · Cited by 14
Functional measures, inflammatory markers and endothelin-1 as predictors of 360-day survival in centenarians
Szewieczek, J., Francuz, T., Duława, J., Legierska, K., Hornik, B., Włodarczyk, I., Janusz-Jenczeń, M., & Batko‐Szwaczka, A. (2015) · AGE · doi:10.1007/s11357-015-9822-9 · Cited by 14
Epidemiological findings of vascular risk factors in Alzheimer’s disease: implications for therapeutic and preventive intervention
Qiu, C. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.146 · Cited by 14
The Effect of Fat Intake with Increased Omega-6-to-Omega-3 Polyunsaturated Fatty Acid Ratio in Animal Models of Early and Late Alzheimer’s Disease-like Pathogenesis
Galeano, P., de Ceglia, M., Mastrogiovanni, M., Campanelli, L., Vera, D. M., Campolo, N., Novack, G. V., Rosell‐Valle, C., Suárez, J., Aicardo, A., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242317009 · Cited by 13
C-reactive protein levels and risk of disabling dementia with and without stroke in Japanese: The Circulatory Risk in Communities Study (CIRCS)
Chei, C., Yamagishi, K., Ikeda, A., Noda, H., Maruyama, M., Cui, R., Imano, H., Kiyama, M., Kitamura, A., Asada, T., et al. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.07.036 · Cited by 13
Association between systemic rheumatic diseases and dementia risk: A meta-analysis
Wang, Y., Lin, M.-S., Huang, A. P., Wu, C.-C., & Kung, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1054246 · Cited by 13
Association of biomarkers for inflammation, endothelial dysfunction and oxidative stress with cognitive impairment: the Epidemiology of Hearing Loss Study
Obasi, C. N., Cruickshanks, K. J., Nondahl, D. M., Klein, R., Klein, R., Nieto, F. J., Shankar, A., Fischer, M., Tsai, M. Y., & Chappell, R. J. (2012) · Oxidants and Antioxidants in Medical Science · doi:10.5455/oams.031212.br.004 · Cited by 13
Early Molecular and Synaptic Dysfunctions In the Prodromal Stages of Alzheimer‘s Disease: Focus on Tnf-α and Il-1β
Cavanagh, C., Colby-Milley, J., Farso, M. C., Krantic, S. M., & Quirion, R. (2011) · Future Neurology · doi:10.2217/fnl.11.50 · Cited by 15
Dietary Inflammation Factor Rating System and Risk of Alzheimer Disease in Elders
Gu, Y., Nieves, J. W., Luchsinger, J. A., & Scarmeas, N. (2010) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e3181ff3c6a · Cited by 13
Thinking outside the black box: are the brain endothelial cells the new main target in Alzheimer’s disease?
Estudillo, E., López-Ornelas, A., Rodríguez-Oviedo, A., Cruz, N. G. D. L., Vargas-Hernández, M. A., & Jiménez, A. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.373672 · Cited by 14
Quantifying Putative Retinal Gliosis in Preclinical Alzheimer's Disease
Ravichandran, S., Snyder, P. J., Alber, J., Kenny, M. R., Rothstein, A., Brown, K., Murchison, C., Clay, O. J., Roberson, E. D., & Arthur, E. (2024) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.65.5.5 · Cited by 12
Oral infections and orofacial pain in Alzheimer's disease: case report and review
de Siqueira, S. R. D. T., Rolim, T. D. S., Teixeira, M. J., Nitríni, R., Anghinah, R., & de Siqueira, J. T. T. (2010) · Dementia & Neuropsychologia · doi:10.1590/s1980-57642010dn40200012 · Cited by 12
Blood Transcriptomic Biomarkers of Alzheimer's Disease Patients Treated with EHT 0202
Désiré, L., Blondiaux, E., Carrière, J., Haddad, R., Sol, O., Fehlbaum, P., Einstein, R., Zhou, W., & Pando, M. P. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121501 · Cited by 12
Associations between IL-1β, IL-6, and TNFα polymorphisms and longitudinal trajectories of cognitive function in non-demented older adults
Lawrence, K. A., Gloger, E. M., Pinheiro, C. N., Schmitt, F. A., & Segerstrom, S. C. (2024) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2024.100816 · Cited by 11
Alterations in Alzheimer’s Disease-Associated Gene Expression in Severe Obstructive Sleep Apnea Patients
Li, H., Tsai, M., Huang, C., Wang, R., Chuang, L., Chen, N., Liu, C., Hsu, C., Cheng, W., & Lee, L. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8091361 · Cited by 11
Approaches for Increasing Cerebral Efflux of Amyloid-β in Experimental Systems
Loeffler, D. A. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240212 · Cited by 12
Oxidative stress and inflammatory response in patients with psoriasis; is there any relationship with psychiatric comorbidity and cognitive functions?
Deveci, E., Kocacenk, T., Şahan, E., Yılmaz, O., Öztürk, A., & Kırpınar, İ. (2019) · Psychiatry and Clinical Psychopharmacology · doi:10.1080/24750573.2019.1589176 · Cited by 12
Cross sectional association between cytomegalovirus seropositivity, inflammation and cognitive impairment in elderly cancer survivors
Vivek, S., Nelson, H. H., Prizment, A. E., Faul, J. D., Crimmins, E. M., & Thyagarajan, B. (2021) · Cancer Causes & Control · doi:10.1007/s10552-021-01504-3 · Cited by 11
Biomarkers in geriatric psychiatry: searching for the holy grail?
Blumberger, D. M., Daskalakis, Z. J., & Mulsant, B. H. (2008) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e328314b763 · Cited by 11
Expression of neprilysin in periodontitis-affected gingival tissues
Nezu, A., Kubota, T., Maruyama, S., Nagata, M., Nohno, K., Morozumi, T., & Yoshie, H. (2017) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2017.03.003 · Cited by 12
Risk of dementia following herpes zoster infection among patients undertreatment versus those not: A systematic review and meta‐analysis
Thapa, S., Shah, S., Bhattarai, A., Panah, M. Y., Chand, S., & Mirmosayyeb, O. (2024) · Health Science Reports · doi:10.1002/hsr2.1941 · Cited by 10
Relationship between Alzheimer’s Disease and the Human Microbiome
Fujii, Y., Khasnobish, A., & Morita, H. (2019) · Codon Publications eBooks · doi:10.15586/alzheimersdisease.2019.ch9 · Cited by 11
Kidney-Metabolic Factors Associated with Cognitive Impairment in Chronic Kidney Disease: A Pilot Study
Murray, A. M., Slinin, Y., Tupper, D. E., Pederson, S. L., Davey, C. S., Gilbertson, D. T., Drawz, P. E., Mello, R. N., Hart, A., Johansen, K. L., et al. (2022) · American Journal of Nephrology · doi:10.1159/000524166 · Cited by 11
Peripheral Leukocytosis Predicts Cognitive Decline but Not Behavioral Disturbances: A Nationwide Study of Alzheimer’s and Parkinson’s Disease Patients
Unda, S. R., Antoniazzi, A. M., Altschul, D., & Marongiu, R. (2021) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000516340 · Cited by 10
CSF TNF α levels were associated with conversion from mild cognitive impairment to dementia
Fu, P., Peng, F., & Initiative, A. D. N. (2022) · PLoS ONE · doi:10.1371/journal.pone.0274503 · Cited by 10
Role of Cerebrospinal Fluid and Plasma Biomarkers in the Diagnosis of Neurodegenerative Disorders and Mild Cognitive Impairment
Gonzalez‐Cuyar, L. F., Sonnen, J. A., Montine, K. S., Keene, C. D., & Montine, T. J. (2011) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-011-0212-0 · Cited by 9
Ellagic Acid Administration Reverses Colchicine- Induced Dementia in Rats
Kaur, J., Kumar, M., & Bansal, N. (2016) · Journal of Pharmaceutical Technology Research and Management · doi:10.15415/jptrm.2016.41003 · Cited by 9
Lack of Association between Tumor Necrosis Factor-alpha -308 G/A Polymorphism and Risk of Developing Late-Onset Alzheimer's Disease in an Iranian Population.
Manoochehri, M., Kamali, K., Rahgozar, M., Ohadi, M., Farrokhi, H., & Khorshid, H. R. K. (2009) · Europe PMC (PubMed Central) · Cited by 8
Epigenetic differences in inflammation genes of monozygotic twins are related to parent-child emotional availability and health
Lewis, C. R., Sowards, H., Huentelman, M. J., Doane, L. D., & Lemery‐Chalfant, K. (2020) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2020.100084 · Cited by 9
Serum levels of resistin and its relationship with some pro-inflammatory cytokines in a cohort of Egyptian patients with Alzheimer's disease
Azzam, E., Elneily, D., Gayar, N. H. E., Elfatatry, A., & Saad, M. (2020) · Endocrine and Metabolic Science · doi:10.1016/j.endmts.2020.100054 · Cited by 8
Cytokine Expression and Production Changes in Very Old Age
McNerlan, S., Armstrong, M., Ross, O. A., & Rea, I. M. (2009) · Springer eBooks · doi:10.1007/978-1-4020-9063-9_40 · Cited by 8
Alzheimer's disease and the immune system: A comprehensive overview with a focus on B cells, humoral immunity, and immunotherapy
Afrakoti, L. G. M. P., Moghadam, S. D., & Hadinezhad, P. (2025) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823251329188 · Cited by 12
The loss of neural synchrony in the post septic brain
Götz, T., Baumbach, P., Reuken, P. A., Huonker, R., Kranczioch, C., Debener, S., Brunkhorst, F. M., Witte, O. W., Klingner, C. M., & Günther, A. (2016) · Clinical Neurophysiology · doi:10.1016/j.clinph.2016.02.006 · Cited by 7
High CRP with “normal” cognition
Buchman, A. S., & Bennett, D. A. (2012) · Neurology · doi:10.1212/wnl.0b013e3182698df4 · Cited by 7
Impact of Helicobacter pylori on chronic hepatitis C-related cognitive dysfunction
Kountouras, J., Zavos, C., Deretzi, G., Gavalas, E., Pοlyzos, S. A., Katsinelos, P., Grigoriadis, N., Koutlas, E., Rudolf, J., & Tsiptsios, I. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.09.022 · Cited by 7
Peripheral Biomarkers in Dementia and Alzheimer's Disease
Humpel, C., & Marksteiner, J. (2009) · Springer eBooks · doi:10.1007/978-1-4020-9838-3_1 · Cited by 6
Systemic Inflammation and Cognition in the Elderly
Trollor, J. N., & Agars, E. (2010) · Springer eBooks · doi:10.1007/978-4-431-53871-4_13 · Cited by 6
A Complex Interplay Between Melatonin and RORβ: RORβ is Unlikely a Putative Receptor for Melatonin as Revealed by Biophysical Assays
Panmanee, J., Charoensutthivarakul, S., Cheng, C. W., Promthep, K., Mukda, S., Prasertporn, T., Nopparat, C., Teerapo, K., Supcharoen, P., Petchyam, N., et al. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04395-y · Cited by 6
Mononuclear cells in dementia
Mandas, A., & Dessı̀, S. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.02.016 · Cited by 8
Inflammation Friend or Foe?
Lewis, T. J., & Trempe, C. L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-812112-2.00007-0 · Cited by 8
Systemic inflammation and modifiable risk factors for cognitive impairment in older persons: Findings from a British birth cohort
Tsui, A., Richards, M., & Davis, D. H. J. (2018) · Aging Medicine · doi:10.1002/agm2.12044 · Cited by 5
Patients with psoriasis have a higher risk of dementia: A systematic review and meta-analysis
Charoenngam, N., Rittiphairoj, T., Ponvilawan, B., & Ungprasert, P. (2021) · Indian Journal of Dermatology Venereology and Leprology · doi:10.25259/ijdvl_732_19 · Cited by 6
Does Osteopathic Manipulative Treatment Make a Neuropsychological Difference in Adults With Pain? A Rationale for a New Approach
Rizkalla, M. N., Henderson, K. K., Huntington-Alfano, K., Heinking, K. P., Koronkiewicz, A., Knees, M., Hoffman, H., Elahi, F., & Impens, A. J. (2018) · Journal of Osteopathic Medicine · doi:10.7556/jaoa.2018.136 · Cited by 6
Human iPSC‐Derived Mononuclear Phagocytes Improve Cognition and Neural Health across Multiple Mouse Models of Aging and Alzheimer's Disease
Moser, V. A., Dimas‐Harms, L. J., Lipman, R. M., Inzalaco, J., Bell, S., Alcantara, M., Valenzuela, E., Lawless, G. M., Kreimer, S. D., Parker, S. J., et al. (2025) · Advanced Science · doi:10.1002/advs.202417848 · Cited by 5
Association between varicella-zoster virus and Alzheimer's disease: A systematic review and meta-analysis of comprehensive evidence from infection, treatment to prevention
Yang, J., & Jiang, J. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877251411573 · Cited by 6
Chronic Inflammation and Innate Immunity in Alzheimer’s Disease—Role of Diet
Bennett, L. E., Nigro, J., Bird, M., Gyengési, E., Macaulay, S. L., & Münch, G. W. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-407824-6.00021-5 · Cited by 5
The Role of Nutrition and Inflammation on Cognition in a High-Risk Group for Alzheimer’s Disease
Jackson, J. M., Bay, A. A., Barter, J., Ni, L., Caudle, W. M., Serra, M. C., Wharton, W., & Hackney, M. E. (2020) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-200224 · Cited by 6
Early Dysregulation of RNA Splicing and Translation Processes Are Key Markers from Mild Cognitive Impairment to Alzheimer’s Disease: An In Silico Transcriptomic Analysis
D’Angiolini, S., Gugliandolo, A., Calì, G., & Chiricosta, L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157303 · Cited by 4
The Central Nervous System and Heart Failure
Dayer, M., MacIver, D. H., & Rosen, S. D. (2020) · Future Cardiology · doi:10.2217/fca-2020-0059 · Cited by 4
Vorzeitige Immunalterung: ein pathogenetischer Faktor bei Alzheimer-Demenz?
Richartz-Salzburger, E., Stransky, E., Laske, C., & Köhler, N. (2010) · Der Nervenarzt · doi:10.1007/s00115-009-2918-7 · Cited by 4
C-Reactive Protein and Neurodegenerative Diseases
Cardoso, I. L., & Leal, M. F. C. (2020) · Springer eBooks · doi:10.1007/978-981-15-6787-2_2 · Cited by 4
Potential of nanoparticles and nanopolymers in treatment of age-associated diseases
Saadatpour, F., Mohammadipanah, F., Zohourian, N., & Hodjat, M. (2021) · Advances in Natural Sciences Nanoscience and Nanotechnology · doi:10.1088/2043-6262/ac42c7 · Cited by 3
Consequences of the Lack of TNFR1 in Ouabain Response in the Hippocampus of C57BL/6J Mice
Kinoshita, P. F., Orellana, A. M., Andreotti, D. Z., de Souza, G. A., de Mello, N. P., Lima, L. D. S., Kawamoto, E. M., & Scavone, C. (2022) · Biomedicines · doi:10.3390/biomedicines10112937 · Cited by 4
Atrial fibrillation and cognitive disorders: An overview on possible correlation
Puccio, D., Vizzini, M. C., Baiamonte, V., Lunetta, M., Evola, S., Galassi, A. R., & Novo, G. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111326 · Cited by 4
Vascular Dementia and Cognitive Impairment
Seshadri, S. S., Economos, A., & Wright, C. B. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-29544-4.00017-7 · Cited by 4
Self-citation
Neuropsychiatry of atrial fibrillation: dementia and beyond
Chaudhari, M., Rodriguez, J., Velasco, A., Agoston, I., Seshadri, S. S., & Teixeira, A. L. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1485837 · Cited by 3
Self-citation
Highlighting the Effect of Pro-inflammatory Mediators in the Pathogenesis of Periodontal Diseases and Alzheimer’s Disease
Hashim, N. T., Babiker, R. A., Mohammed, R., Chaitanya, N. C., Rahman, M. M., & Gismalla, B. G. (2024) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/jpbs.jpbs_1120_23 · Cited by 4
Metabolic and Immune Risk Factors for Dementia and their Modification by Flavonoids: New Targets for the Prevention of Cognitive Impairment?
Saunders, C., & Spencer, J. P. E. (2012) · Nutrition and Aging · doi:10.3233/nua-2012-0008 · Cited by 3
Vascular Dementia and Cognitive Impairment
Seshadri, S. S., Caunca, M. R., & Rundek, T. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-69424-7.00018-1 · Cited by 3
Self-citation
The Impact of Uremic Toxins on Alzheimer's Disease
Zheng, Y., Ji, B., Chen, S., Zhou, R., & Ni, R. (2022) · Current Alzheimer Research · doi:10.2174/1567205019666220120113305 · Cited by 3
Midlife Systemic Inflammatory Markers Are Associated With Late-Life Brain Volume
Walker, K. A., Hoogeveen, R. C., Folsom, A. R., Ballantyne, C. M., Knopman, D. S., Windham, B. G., Jack, C. R., & Gottesman, R. F. (2023) · Neurology · doi:10.1212/wnl.0000000000207681 · Cited by 3
Biomarkers of Disorders of the Nervous System
Jain, K. K. (2017) · Springer eBooks · doi:10.1007/978-1-4939-7431-3_14 · Cited by 3
Inflammation-associated risk factors for Alzheimer s disease and dementia
Eriksson, U. K. (2010) · Figshare · Cited by 3
Systemic inflammation, delirium and clinical progression in mild-moderate Alzheimer disease
Dyer, A. H., Dolphin, H., Morrison, L., Kenny, T., Fallon, P. G., Cunningham, C. M., O’Connor, A., LAWLOR, B. A., O’Farrelly, C., Bourke, N. M., et al. (2026) · EBioMedicine · doi:10.1016/j.ebiom.2026.106159 · Cited by 3
Gastrodin and gastrodigenin: advancing neurogenesis in neurological disease management
Ma, W., Wang, S., Yang, X., Chen, Y.-B., Li, Y., & Cui, Y. L. (2026) · Food Research International · doi:10.1016/j.foodres.2026.118882 · Cited by 2
Alzheimer Disease
Коган, М. И., & Jeong, H.-S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35868-2.00011-6 · Cited by 2
Expression analysis of inhibitory B7 family members in Alzheimer’s disease
Sabaie, H., Tamimi, P., Gharesouran, J., Salkhordeh, Z., Asadi, M. R., Sharifi‐Bonab, M., Shirvani-Farsani, Z., Taheri, M. N., Sayad, A., & Rezazadeh, M. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01274-8 · Cited by 2
Cognitive function is associated with performance in time up and go test and with leptin blood levels in community-dwelling older women
Teixeira, L. A. D. C., Soares, L. A., Lima, L. P., de Avelar, N. C. P., de Moura, J. A., Leopoldino, A. A. O., Figueiredo, P. H. S., Parentoni, A. N., Mendonça, V. A., & Lacerda, A. C. R. (2024) · Scientific Reports · doi:10.1038/s41598-024-60274-5 · Cited by 3
Animal Models of Vascular Cognitive Disorder after Myocardial Infarction: Scoping Review
Petrov, A. V., Shnayder, N. A., Петрова, М. М., Evsyukov, A. A., Kaskaeva, D. S., Дмитренко, Д. В., & Malinovskaya, N. A. (2024) · Personalized Psychiatry and Neurology · doi:10.52667/2712-9179-2024-4-3-24-36 · Cited by 2
Plasma leptin, resistin, tumor necrosis factor-alpha, and interleukin-6 with risk of dementia: A prospective population study
Zhang, P., Wu, N., Xue, Q., Li, J., Ouyang, Q., Yu, X., Yang, Y., Dong, Y., Li, F., Wang, T., et al. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251352480 · Cited by 2
Cardiometabolic Risk, Inflammation, and Neurodegenerative Disorders
Palavra, F., Ciampi, E., & Sena, A. (2015) · Springer eBooks · doi:10.1007/978-3-319-16018-4_7 · Cited by 2
Elevated platelet microparticles levels are associated with lipidic oxidation and inflammatory profiles in Alzheimer's disease
Gonçalves, G. S., Duarte, R. C. F., Campos, F. M. F., Silva, I. D. F. O., Sousa, L. P., Faria, M. C., Martins‐Filho, O. A., Bicalho, M. A. C., de Moraes, E. N., Teixeira, A. L., et al. (2016) · European Geriatric Medicine · doi:10.1016/j.eurger.2016.05.001 · Cited by 3
Knee arthroplasty can preserve cognitive function in patients with severe knee osteoarthritis
Heo, J., Baek, J., Nam, C. H., Kim, T., Ahn, H. S., & Lee, S.-C. (2025) · PLoS ONE · doi:10.1371/journal.pone.0317707 · Cited by 1
Peripheral inflammation in a Canadian cohort of neurodegenerative conditions: Occurrence, determinants, and impact
Lima, B. S., Rosa‐Neto, P., Phillips, N. A., BORRIE, M. J., Roncero, C. T., Lahiri, D., Dori, D., Eintracht, S., & Chertkow, H. M. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251401611 · Cited by 1

Authors: Tan, Z. S., Beiser, A. S., Vasan, R. S., Roubenoff, R., Dinarello, C. A., Harris, T. B., Benjamin, E. J., Au, R., Kiel, D. P., Wolf, P. A., & Seshadri, S.
Affiliations: Boston University (US)
ORCID: Tan, Z. S.
Beiser, A. S.
Vasan, R. S.
Roubenoff, R.
Dinarello, C. A.
Harris, T. B.
Benjamin, E. J.
Au, R.
Kiel, D. P.
Wolf, P. A.
Seshadri, S.
Venue: Neurology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2007-05-29
Volume: 68
Issue: 22
Pages: 1902-1908
ISSN: 0028-3878 (ISSN-L)
1526-632X
DOI: 10.1212/01.wnl.0000263217.36439.da
OpenAlex: W2106118263
Cited by: 440
References: 43
Citations by year: 2026: 6 · 2025: 10 · 2024: 21 · 2023: 14 · 2022: 18 · 2021: 16 · 2020: 22 · 2019: 20 · 2018: 25 · 2017: 34 · 2016: 26 · 2015: 22 · 2014: 34 · 2013: 28 · 2012: 35
FWCI: 15.90
Type: journal article
Language: en
Open access: closed
Locations: Neurology (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (n01hc25195-41-0-1)
National Institute on Aging (5R01 AG 16495, R01AG016495, 5-R01-AG-08122, P30AG013846, R01AG008122, P30-AG13846))
National Heart, Lung, and Blood Institute (N01‐HC25195)
National Institute of Neurological Disorders and Stroke (5-R01-NS-17950, R01NS017950)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords: Alzheimer's disease, inflammatory markers, serum cytokines, peripheral blood mononuclear cells, interleukin-1, TNF-α, interleukin-1 receptor antagonist, C-reactive protein, interleukin-6, inflammation, dementia risk, older adults
MeSH terms: Aged, Alzheimer Disease, C-Reactive Protein, Enzyme-Linked Immunosorbent Assay, Female, Humans, Inflammation, Interleukin-1, Leukocytes, Mononuclear, Male, Neuropsychological Tests, Risk Factors, Tumor Necrosis Factor-alpha, Biomarkers, Interleukin-6, Cytokines, Immunoprecipitation, Interleukin 1 Receptor Antagonist Protein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Inflammatory markers and the risk of Alzheimer disease: The Framingham Study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks